Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 141Active not recruiting 58Terminated 57Recruiting 41Withdrawn 18Unknown 12Not yet recruiting 10Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Astrocytoma 1

Interventions

toripalimab 1tislelizumab 1pembrolizumab 1ibrutinib 1fludarabine 1dynorphin-converting endopeptidase 1Spinal Puncture 1Propranolol 1Positron-Emission Tomography 1Nivolumab 1Magnetic Resonance Imaging 1JNJ-64619178 1JNJ-64264681 1Gemcitabine 1Dexamethasone 1Deoxycholic Acid 1Cyclophosphamide 1Cisplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Enrolling by invitation × Nivolumab × Clear all
NCT06896110 2025-06-26

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

University of Iowa

Phase 1 Enrolling by invitation
34 enrolled
CNS

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡